In2Bones
In2Bones is a Memphis-based orthopedic medical device company specializing in foot and ankle surgical solutions, offering implants, biologics, fixation devices, and powered instruments to orthopedic surgeons and hospitals globally through its integration with CONMED.
- Company typePublic
- Founded1970
- HeadquartersMemphis, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What In2Bones does
In2Bones is a US-based orthopedic medical device company founded in 2014 and headquartered in Memphis, Tennessee, focused on the design, manufacture, and commercialization of surgical products for the foot and ankle. The company built a comprehensive portfolio spanning fracture fixation plates and screws, soft tissue and ligament reconstruction implants, suture anchors, biologic scaffolds, and powered surgical instruments. Named product families include BioBrace® (a reinforced bioinductive implant combining PLLA and collagen for soft tissue reinforcement), QUANTUM® (a total ankle arthroplasty system with OrthoPlanify patient-specific instrumentation), NeoSpan® and Hercules® (fixation systems), CartiMax® (cartilage repair), MicroFree® (powered handpiece platform), TruShot® (microfracture awl), and CoLink® / TenoLok® / Y-Knot® (suture and tendon fixation technologies).
The company monetizes through unit sales of implants, disposable instrument components, and reusable instrument sets sold to hospitals, ambulatory surgery centers, and orthopedic surgeons. Its go-to-market is a direct-and-distributor hybrid model focused on foot and ankle specialists. In 2019, In2Bones was acquired by CONMED Corporation, and its products are now sold as part of CONMED's Foot and Ankle franchise with distribution reach across 100+ countries. The business model is fundamentally a specialty medical device hardware sale — one-time revenue per procedure, no recurring SaaS or consumable subscription layer, and no disclosed direct-to-patient or value-based-care contracting in the data.
In2Bones firmographics
Firmographics- Name
- In2Bones
- Legal name
- CONMED Corporation
- Website
- https://i2b-usa.com
- Company type
- Public
- Founded year
- 1970
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- In2Bones is a Memphis-based orthopedic medical device company specializing in foot and ankle surgical solutions, offering implants, biologics, fixation devices, and powered instruments to orthopedic surgeons and hospitals globally through its integration with CONMED.
- Ownership category
- akta.pro rank
In2Bones industry classification
Industry- Product category
- Orthopedic Implants
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)
- akta.pro secondary industry
- Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)
Keywords
Where In2Bones is headquartered
LocationHeadquarters
- HQ city
- Memphis
- HQ country
- United States
- HQ region
- North America
Markets served
In2Bones business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Device and Surgical Product Sales: CONMED generates revenue through the sale of medical devices, surgical implants, fixation devices, biologics, and surgical instrumentation to healthcare providers and surgical facilities.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
In2Bones product offering
Product offeringCore offering
In2Bones designs, manufactures, and markets orthopedic implants and instrumentation for the upper and lower extremities. The company's product portfolio spans soft-tissue fixation, plating systems, compression screws, allograft implants, and surgical tools used by foot and ankle surgeons, orthopedic specialists, and surgical centers.
Product overview
CONMED is a medical device company offering a comprehensive portfolio of foot and ankle surgical solutions. The product ecosystem includes arthroplasty systems (QUANTUM® Total Ankle with OrthoPlanify™ PSI), fixation devices (NeoSpan® Compression Implant System, CoLink® plating systems), biologics (CartiMax® cartilage allograft), implants and suture anchors (BioBrace®, Hercules® anchors, TruShot® with Y-Knot®), surgical power tools (MicroFree®), and instrumentation. Products are organized by surgical application including Sports Medicine, Forefoot & Midfoot, Hindfoot & Ankle, and Biologics categories.
Differentiator
Problem solved
Functional benefit
Brands
- CONMED Foot and Ankle: Product division specializing in surgical solutions for foot and ankle procedures, including arthroplasty, biologics, fixation, implants, suture anchors, and instrumentation.
Products and services
- BioBrace
Quantifiable outcome
- 14 Nitinol options in NeoSpan® Compression Implant System
- +1 more outcomes
Companies that use In2Bones
Customer profileSegments2 records
Ideal customer profiles1 record
In2Bones technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
In2Bones partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
In2Bones competitors and assessment
Company assessmentDirect peers
- Acumed: Specialist in orthopedic implants and instrumentation for the upper and lower extremities, with plating, fracture fixation, and small-bone systems directly overlapping In2Bones' portfolio.
- Paragon 28: Pure-play foot and ankle orthopedic company offering implants, fixation, biologics, and instrumentation across the same surgical specialties In2Bones targets, with comparable product breadth and customer base.
- Arthrex: Global orthopedic device company with deep extremity, sports medicine, and soft-tissue fixation portfolios (including suture anchors and small-joint arthroplasty) that overlap with In2Bones' sports-medicine foot/ankle offerings.
- Vilex: Foot and ankle focused orthopedic company producing plates, screws, and specialty implants for forefoot, midfoot, and hindfoot procedures — closely comparable to In2Bones' CoLink® plating family.
Broad incumbents
- Wright Medical (now Stryker): Historically a leading foot and ankle extremity franchise (now integrated into Stryker) offering total ankle, plating, and biologics that compete head-on with In2Bones' extremity portfolio.
- Stryker: Diversified orthopedic major with extremity, foot/ankle, sports medicine, and surgical power-tool lines that compete broadly with In2Bones across multiple product families.
- DePuy Synthes (Johnson & Johnson): Largest orthopedic franchise globally with extremity trauma plates, screws, and small-bone power systems overlapping In2Bones' fixation and instrumentation offerings.
- Zimmer Biomet: Broad-line orthopedic device manufacturer with extremity, foot/ankle, sports medicine, and biologics portfolios that overlap with several of In2Bones' product categories.
- Smith+Nephew: Global medical device company with sports medicine, extremity, and arthroscopy lines that overlap with In2Bones' suture anchor, soft-tissue, and small-bone power offerings.
Emerging players
- Conventus Orthopaedics: Extremity-focused orthopedic company with proprietary cage/plate technology for fractures of the proximal humerus, distal radius, and proximal tibia — a comparable smaller specialist in adjacent extremity indications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
In2Bones social profiles
Digital presenceIn2Bones financial estimates
Financial estimateRevenue estimate
Valuation estimate
In2Bones leadership team
Management profileNumber of profiles
Profiles2 records
In2Bones funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
In2Bones M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about In2Bones
What does In2Bones do?
In2Bones designs, manufactures, and markets orthopedic implants and instrumentation for the upper and lower extremities. The company's product portfolio spans soft-tissue fixation, plating systems, compression screws, allograft implants, and surgical tools used by foot and ankle surgeons, orthopedic specialists, and surgical centers.
Is In2Bones a public or private company?
In2Bones is a public company. It is classified as unknown and is currently operating.
When was In2Bones founded?
In2Bones was founded in 1970. It employs 51 to 100 people.
Where is In2Bones based?
In2Bones is headquartered in Memphis, United States, in the North America region.
How does In2Bones make money?
One revenue line is on record: medical Device and Surgical Product Sales.
Who are In2Bones's main competitors?
Direct peers on record are Acumed, Paragon 28, Arthrex and Vilex. Broad incumbents are Wright Medical (now Stryker), Stryker, DePuy Synthes (Johnson & Johnson), Zimmer Biomet and Smith+Nephew. Conventus Orthopaedics is listed as an emerging player.
Does In2Bones have an API?
No public API is recorded for In2Bones.
What industry is In2Bones in?
In2Bones's product category is Orthopedic Implants. Its primary akta.pro industry code is HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation), with a secondary code of HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle). Its NAICS code is 339113 and its SIC code is 3842.